Global Osteoarthritis Pain Drugs Market Research Report 2021

Global Osteoarthritis Pain Drugs Market Research Report 2021

Table of Contents
1 Osteoarthritis Pain Drugs Market Overview
1.1 Product Overview and Scope of Osteoarthritis Pain Drugs
1.2 Osteoarthritis Pain Drugs Segment by Type
1.2.1 Global Osteoarthritis Pain Drugs Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Oral
1.2.3 Injection
1.2.4 External
1.3 Osteoarthritis Pain Drugs Segment by Application
1.3.1 Osteoarthritis Pain Drugs Sales Comparison by Application: (2021-2027)
1.3.2 Medical Care
1.3.3 Personal Care
1.4 Global Osteoarthritis Pain Drugs Market Size Estimates and Forecasts
1.4.1 Global Osteoarthritis Pain Drugs Revenue 2016-2027
1.4.2 Global Osteoarthritis Pain Drugs Sales 2016-2027
1.4.3 Osteoarthritis Pain Drugs Market Size by Region: 2016 Versus 2021 Versus 2027
2 Osteoarthritis Pain Drugs Market Competition by Manufacturers
2.1 Global Osteoarthritis Pain Drugs Sales Market Share by Manufacturers (2016-2021)
2.2 Global Osteoarthritis Pain Drugs Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Osteoarthritis Pain Drugs Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Osteoarthritis Pain Drugs Manufacturing Sites, Area Served, Product Type
2.5 Osteoarthritis Pain Drugs Market Competitive Situation and Trends
2.5.1 Osteoarthritis Pain Drugs Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Osteoarthritis Pain Drugs Players Market Share by Revenue
2.5.3 Global Osteoarthritis Pain Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Osteoarthritis Pain Drugs Retrospective Market Scenario by Region
3.1 Global Osteoarthritis Pain Drugs Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Osteoarthritis Pain Drugs Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Osteoarthritis Pain Drugs Market Facts & Figures by Country
3.3.1 North America Osteoarthritis Pain Drugs Sales by Country
3.3.2 North America Osteoarthritis Pain Drugs Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Osteoarthritis Pain Drugs Market Facts & Figures by Country
3.4.1 Europe Osteoarthritis Pain Drugs Sales by Country
3.4.2 Europe Osteoarthritis Pain Drugs Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Osteoarthritis Pain Drugs Market Facts & Figures by Region
3.5.1 Asia Pacific Osteoarthritis Pain Drugs Sales by Region
3.5.2 Asia Pacific Osteoarthritis Pain Drugs Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Osteoarthritis Pain Drugs Market Facts & Figures by Country
3.6.1 Latin America Osteoarthritis Pain Drugs Sales by Country
3.6.2 Latin America Osteoarthritis Pain Drugs Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Osteoarthritis Pain Drugs Market Facts & Figures by Country
3.7.1 Middle East and Africa Osteoarthritis Pain Drugs Sales by Country
3.7.2 Middle East and Africa Osteoarthritis Pain Drugs Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Osteoarthritis Pain Drugs Historic Market Analysis by Type
4.1 Global Osteoarthritis Pain Drugs Sales Market Share by Type (2016-2021)
4.2 Global Osteoarthritis Pain Drugs Revenue Market Share by Type (2016-2021)
4.3 Global Osteoarthritis Pain Drugs Price by Type (2016-2021)
5 Global Osteoarthritis Pain Drugs Historic Market Analysis by Application
5.1 Global Osteoarthritis Pain Drugs Sales Market Share by Application (2016-2021)
5.2 Global Osteoarthritis Pain Drugs Revenue Market Share by Application (2016-2021)
5.3 Global Osteoarthritis Pain Drugs Price by Application (2016-2021)
6 Key Companies Profiled
6.1 Sino Biopharmaceutical
6.1.1 Sino Biopharmaceutical Corporation Information
6.1.2 Sino Biopharmaceutical Description and Business Overview
6.1.3 Sino Biopharmaceutical Osteoarthritis Pain Drugs Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Sino Biopharmaceutical Product Portfolio
6.1.5 Sino Biopharmaceutical Recent Developments/Updates
6.2 Chugai Pharmaceutical
6.2.1 Chugai Pharmaceutical Corporation Information
6.2.2 Chugai Pharmaceutical Description and Business Overview
6.2.3 Chugai Pharmaceutical Osteoarthritis Pain Drugs Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Chugai Pharmaceutical Product Portfolio
6.2.5 Chugai Pharmaceutical Recent Developments/Updates
6.3 Pfizer
6.3.1 Pfizer Corporation Information
6.3.2 Pfizer Description and Business Overview
6.3.3 Pfizer Osteoarthritis Pain Drugs Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Pfizer Product Portfolio
6.3.5 Pfizer Recent Developments/Updates
6.4 Mikasa Seiyaku
6.4.1 Mikasa Seiyaku Corporation Information
6.4.2 Mikasa Seiyaku Description and Business Overview
6.4.3 Mikasa Seiyaku Osteoarthritis Pain Drugs Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Mikasa Seiyaku Product Portfolio
6.4.5 Mikasa Seiyaku Recent Developments/Updates
6.5 Bayer
6.5.1 Bayer Corporation Information
6.5.2 Bayer Description and Business Overview
6.5.3 Bayer Osteoarthritis Pain Drugs Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Bayer Product Portfolio
6.5.5 Bayer Recent Developments/Updates
6.6 Haohai Biological
6.6.1 Haohai Biological Corporation Information
6.6.2 Haohai Biological Description and Business Overview
6.6.3 Haohai Biological Osteoarthritis Pain Drugs Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Haohai Biological Product Portfolio
6.6.5 Haohai Biological Recent Developments/Updates
6.7 SK Chemicals
6.6.1 SK Chemicals Corporation Information
6.6.2 SK Chemicals Description and Business Overview
6.6.3 SK Chemicals Osteoarthritis Pain Drugs Sales, Revenue and Gross Margin (2016-2021)
6.4.4 SK Chemicals Product Portfolio
6.7.5 SK Chemicals Recent Developments/Updates
6.8 Taisho Pharmaceutical
6.8.1 Taisho Pharmaceutical Corporation Information
6.8.2 Taisho Pharmaceutical Description and Business Overview
6.8.3 Taisho Pharmaceutical Osteoarthritis Pain Drugs Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Taisho Pharmaceutical Product Portfolio
6.8.5 Taisho Pharmaceutical Recent Developments/Updates
6.9 Zhejiang Chengyi Pharmaceutical
6.9.1 Zhejiang Chengyi Pharmaceutical Corporation Information
6.9.2 Zhejiang Chengyi Pharmaceutical Description and Business Overview
6.9.3 Zhejiang Chengyi Pharmaceutical Osteoarthritis Pain Drugs Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Zhejiang Chengyi Pharmaceutical Product Portfolio
6.9.5 Zhejiang Chengyi Pharmaceutical Recent Developments/Updates
6.10 Freda
6.10.1 Freda Corporation Information
6.10.2 Freda Description and Business Overview
6.10.3 Freda Osteoarthritis Pain Drugs Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Freda Product Portfolio
6.10.5 Freda Recent Developments/Updates
6.11 Bright Future
6.11.1 Bright Future Corporation Information
6.11.2 Bright Future Osteoarthritis Pain Drugs Description and Business Overview
6.11.3 Bright Future Osteoarthritis Pain Drugs Sales, Revenue and Gross Margin (2016-2021)
6.11.4 Bright Future Product Portfolio
6.11.5 Bright Future Recent Developments/Updates
6.12 Jingfeng Pharmaceutical
6.12.1 Jingfeng Pharmaceutical Corporation Information
6.12.2 Jingfeng Pharmaceutical Osteoarthritis Pain Drugs Description and Business Overview
6.12.3 Jingfeng Pharmaceutical Osteoarthritis Pain Drugs Sales, Revenue and Gross Margin (2016-2021)
6.12.4 Jingfeng Pharmaceutical Product Portfolio
6.12.5 Jingfeng Pharmaceutical Recent Developments/Updates
6.13 Seikagaku Corporation
6.13.1 Seikagaku Corporation Corporation Information
6.13.2 Seikagaku Corporation Osteoarthritis Pain Drugs Description and Business Overview
6.13.3 Seikagaku Corporation Osteoarthritis Pain Drugs Sales, Revenue and Gross Margin (2016-2021)
6.13.4 Seikagaku Corporation Product Portfolio
6.13.5 Seikagaku Corporation Recent Developments/Updates
6.14 GSK
6.14.1 GSK Corporation Information
6.14.2 GSK Osteoarthritis Pain Drugs Description and Business Overview
6.14.3 GSK Osteoarthritis Pain Drugs Sales, Revenue and Gross Margin (2016-2021)
6.14.4 GSK Product Portfolio
6.14.5 GSK Recent Developments/Updates
6.15 Sanofi
6.15.1 Sanofi Corporation Information
6.15.2 Sanofi Osteoarthritis Pain Drugs Description and Business Overview
6.15.3 Sanofi Osteoarthritis Pain Drugs Sales, Revenue and Gross Margin (2016-2021)
6.15.4 Sanofi Product Portfolio
6.15.5 Sanofi Recent Developments/Updates
6.16 Crystal Genomics
6.16.1 Crystal Genomics Corporation Information
6.16.2 Crystal Genomics Osteoarthritis Pain Drugs Description and Business Overview
6.16.3 Crystal Genomics Osteoarthritis Pain Drugs Sales, Revenue and Gross Margin (2016-2021)
6.16.4 Crystal Genomics Product Portfolio
6.16.5 Crystal Genomics Recent Developments/Updates
6.17 Johnson & Johnson
6.17.1 Johnson & Johnson Corporation Information
6.17.2 Johnson & Johnson Osteoarthritis Pain Drugs Description and Business Overview
6.17.3 Johnson & Johnson Osteoarthritis Pain Drugs Sales, Revenue and Gross Margin (2016-2021)
6.17.4 Johnson & Johnson Product Portfolio
6.17.5 Johnson & Johnson Recent Developments/Updates
6.18 GlaxoSmithKline
6.18.1 GlaxoSmithKline Corporation Information
6.18.2 GlaxoSmithKline Osteoarthritis Pain Drugs Description and Business Overview
6.18.3 GlaxoSmithKline Osteoarthritis Pain Drugs Sales, Revenue and Gross Margin (2016-2021)
6.18.4 GlaxoSmithKline Product Portfolio
6.18.5 GlaxoSmithKline Recent Developments/Updates
6.19 Mylan
6.19.1 Mylan Corporation Information
6.19.2 Mylan Osteoarthritis Pain Drugs Description and Business Overview
6.19.3 Mylan Osteoarthritis Pain Drugs Sales, Revenue and Gross Margin (2016-2021)
6.19.4 Mylan Product Portfolio
6.19.5 Mylan Recent Developments/Updates
6.20 Lilly
6.20.1 Lilly Corporation Information
6.20.2 Lilly Osteoarthritis Pain Drugs Description and Business Overview
6.20.3 Lilly Osteoarthritis Pain Drugs Sales, Revenue and Gross Margin (2016-2021)
6.20.4 Lilly Product Portfolio
6.20.5 Lilly Recent Developments/Updates
6.21 Abbott Laboratories
6.21.1 Abbott Laboratories Corporation Information
6.21.2 Abbott Laboratories Osteoarthritis Pain Drugs Description and Business Overview
6.21.3 Abbott Laboratories Osteoarthritis Pain Drugs Sales, Revenue and Gross Margin (2016-2021)
6.21.4 Abbott Laboratories Product Portfolio
6.21.5 Abbott Laboratories Recent Developments/Updates
6.22 Almatica Pharma
6.22.1 Almatica Pharma Corporation Information
6.22.2 Almatica Pharma Osteoarthritis Pain Drugs Description and Business Overview
6.22.3 Almatica Pharma Osteoarthritis Pain Drugs Sales, Revenue and Gross Margin (2016-2021)
6.22.4 Almatica Pharma Product Portfolio
6.22.5 Almatica Pharma Recent Developments/Updates
6.23 TEVA
6.23.1 TEVA Corporation Information
6.23.2 TEVA Osteoarthritis Pain Drugs Description and Business Overview
6.23.3 TEVA Osteoarthritis Pain Drugs Sales, Revenue and Gross Margin (2016-2021)
6.23.4 TEVA Product Portfolio
6.23.5 TEVA Recent Developments/Updates
6.24 Iroko Pharmaceuticals
6.24.1 Iroko Pharmaceuticals Corporation Information
6.24.2 Iroko Pharmaceuticals Osteoarthritis Pain Drugs Description and Business Overview
6.24.3 Iroko Pharmaceuticals Osteoarthritis Pain Drugs Sales, Revenue and Gross Margin (2016-2021)
6.24.4 Iroko Pharmaceuticals Product Portfolio
6.24.5 Iroko Pharmaceuticals Recent Developments/Updates
7 Osteoarthritis Pain Drugs Manufacturing Cost Analysis
7.1 Osteoarthritis Pain Drugs Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Osteoarthritis Pain Drugs
7.4 Osteoarthritis Pain Drugs Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Osteoarthritis Pain Drugs Distributors List
8.3 Osteoarthritis Pain Drugs Customers
9 Osteoarthritis Pain Drugs Market Dynamics
9.1 Osteoarthritis Pain Drugs Industry Trends
9.2 Osteoarthritis Pain Drugs Growth Drivers
9.3 Osteoarthritis Pain Drugs Market Challenges
9.4 Osteoarthritis Pain Drugs Market Restraints
10 Global Market Forecast
10.1 Osteoarthritis Pain Drugs Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Osteoarthritis Pain Drugs by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Osteoarthritis Pain Drugs by Type (2022-2027)
10.2 Osteoarthritis Pain Drugs Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Osteoarthritis Pain Drugs by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Osteoarthritis Pain Drugs by Application (2022-2027)
10.3 Osteoarthritis Pain Drugs Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Osteoarthritis Pain Drugs by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Osteoarthritis Pain Drugs by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Osteoarthritis Pain Drugs Sales (M Dose) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Osteoarthritis Pain Drugs Sales (M Dose) Comparison by Application (2021-2027)
Table 3. Global Osteoarthritis Pain Drugs Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Osteoarthritis Pain Drugs Covered in This Study
Table 5. Global Osteoarthritis Pain Drugs Sales (M Dose) of Key Manufacturers (2016-2021)
Table 6. Global Osteoarthritis Pain Drugs Sales Share by Manufacturers (2016-2021)
Table 7. Global Osteoarthritis Pain Drugs Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Osteoarthritis Pain Drugs Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Osteoarthritis Pain Drugs Average Price (USD/Dose) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Osteoarthritis Pain Drugs Manufacturing Sites and Area Served
Table 11. Manufacturers Osteoarthritis Pain Drugs Product Type
Table 12. Global Osteoarthritis Pain Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Osteoarthritis Pain Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Osteoarthritis Pain Drugs as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Osteoarthritis Pain Drugs Sales by Region (2016-2021) & (M Dose)
Table 16. Global Osteoarthritis Pain Drugs Sales Market Share by Region (2016-2021)
Table 17. Global Osteoarthritis Pain Drugs Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Osteoarthritis Pain Drugs Sales by Country (2016-2021) & (M Dose)
Table 19. North America Osteoarthritis Pain Drugs Sales Market Share by Country (2016-2021)
Table 20. North America Osteoarthritis Pain Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Osteoarthritis Pain Drugs Revenue Market Share by Country (2016-2021)
Table 22. Europe Osteoarthritis Pain Drugs Sales by Country (2016-2021) & (M Dose)
Table 23. Europe Osteoarthritis Pain Drugs Sales Market Share by Country (2016-2021)
Table 24. Europe Osteoarthritis Pain Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Osteoarthritis Pain Drugs Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Osteoarthritis Pain Drugs Sales by Region (2016-2021) & (M Dose)
Table 27. Asia Pacific Osteoarthritis Pain Drugs Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Osteoarthritis Pain Drugs Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Osteoarthritis Pain Drugs Revenue Market Share by Region (2016-2021)
Table 30. Latin America Osteoarthritis Pain Drugs Sales by Country (2016-2021) & (M Dose)
Table 31. Latin America Osteoarthritis Pain Drugs Sales Market Share by Country (2016-2021)
Table 32. Latin America Osteoarthritis Pain Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Osteoarthritis Pain Drugs Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Osteoarthritis Pain Drugs Sales by Country (2016-2021) & (M Dose)
Table 35. Middle East and Africa Osteoarthritis Pain Drugs Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Osteoarthritis Pain Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Osteoarthritis Pain Drugs Revenue Market Share by Country (2016-2021)
Table 38. Global Osteoarthritis Pain Drugs Sales (M Dose) by Type (2016-2021)
Table 39. Global Osteoarthritis Pain Drugs Sales Market Share by Type (2016-2021)
Table 40. Global Osteoarthritis Pain Drugs Revenue (Million US$) by Type (2016-2021)
Table 41. Global Osteoarthritis Pain Drugs Revenue Share by Type (2016-2021)
Table 42. Global Osteoarthritis Pain Drugs Price (USD/Dose) by Type (2016-2021)
Table 43. Global Osteoarthritis Pain Drugs Sales (M Dose) by Application (2016-2021)
Table 44. Global Osteoarthritis Pain Drugs Sales Market Share by Application (2016-2021)
Table 45. Global Osteoarthritis Pain Drugs Revenue (Million US$) by Application (2016-2021)
Table 46. Global Osteoarthritis Pain Drugs Revenue Share by Application (2016-2021)
Table 47. Global Osteoarthritis Pain Drugs Price (USD/Dose) by Application (2016-2021)
Table 48. Sino Biopharmaceutical Corporation Information
Table 49. Sino Biopharmaceutical Description and Business Overview
Table 50. Sino Biopharmaceutical Osteoarthritis Pain Drugs Sales (M Dose), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 51. Sino Biopharmaceutical Osteoarthritis Pain Drugs Product
Table 52. Sino Biopharmaceutical Recent Developments/Updates
Table 53. Chugai Pharmaceutical Corporation Information
Table 54. Chugai Pharmaceutical Description and Business Overview
Table 55. Chugai Pharmaceutical Osteoarthritis Pain Drugs Sales (M Dose), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 56. Chugai Pharmaceutical Osteoarthritis Pain Drugs Product
Table 57. Chugai Pharmaceutical Recent Developments/Updates
Table 58. Pfizer Corporation Information
Table 59. Pfizer Description and Business Overview
Table 60. Pfizer Osteoarthritis Pain Drugs Sales (M Dose), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 61. Pfizer Osteoarthritis Pain Drugs Product
Table 62. Pfizer Recent Developments/Updates
Table 63. Mikasa Seiyaku Corporation Information
Table 64. Mikasa Seiyaku Description and Business Overview
Table 65. Mikasa Seiyaku Osteoarthritis Pain Drugs Sales (M Dose), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 66. Mikasa Seiyaku Osteoarthritis Pain Drugs Product
Table 67. Mikasa Seiyaku Recent Developments/Updates
Table 68. Bayer Corporation Information
Table 69. Bayer Description and Business Overview
Table 70. Bayer Osteoarthritis Pain Drugs Sales (M Dose), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 71. Bayer Osteoarthritis Pain Drugs Product
Table 72. Bayer Recent Developments/Updates
Table 73. Haohai Biological Corporation Information
Table 74. Haohai Biological Description and Business Overview
Table 75. Haohai Biological Osteoarthritis Pain Drugs Sales (M Dose), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 76. Haohai Biological Osteoarthritis Pain Drugs Product
Table 77. Haohai Biological Recent Developments/Updates
Table 78. SK Chemicals Corporation Information
Table 79. SK Chemicals Description and Business Overview
Table 80. SK Chemicals Osteoarthritis Pain Drugs Sales (M Dose), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 81. SK Chemicals Osteoarthritis Pain Drugs Product
Table 82. SK Chemicals Recent Developments/Updates
Table 83. Taisho Pharmaceutical Corporation Information
Table 84. Taisho Pharmaceutical Description and Business Overview
Table 85. Taisho Pharmaceutical Osteoarthritis Pain Drugs Sales (M Dose), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 86. Taisho Pharmaceutical Osteoarthritis Pain Drugs Product
Table 87. Taisho Pharmaceutical Recent Developments/Updates
Table 88. Zhejiang Chengyi Pharmaceutical Corporation Information
Table 89. Zhejiang Chengyi Pharmaceutical Description and Business Overview
Table 90. Zhejiang Chengyi Pharmaceutical Osteoarthritis Pain Drugs Sales (M Dose), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 91. Zhejiang Chengyi Pharmaceutical Osteoarthritis Pain Drugs Product
Table 92. Zhejiang Chengyi Pharmaceutical Recent Developments/Updates
Table 93. Freda Corporation Information
Table 94. Freda Description and Business Overview
Table 95. Freda Osteoarthritis Pain Drugs Sales (M Dose), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 96. Freda Osteoarthritis Pain Drugs Product
Table 97. Freda Recent Developments/Updates
Table 98. Bright Future Corporation Information
Table 99. Bright Future Description and Business Overview
Table 100. Bright Future Osteoarthritis Pain Drugs Sales (M Dose), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 101. Bright Future Osteoarthritis Pain Drugs Product
Table 102. Bright Future Recent Developments/Updates
Table 103. Jingfeng Pharmaceutical Corporation Information
Table 104. Jingfeng Pharmaceutical Description and Business Overview
Table 105. Jingfeng Pharmaceutical Osteoarthritis Pain Drugs Sales (M Dose), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 106. Jingfeng Pharmaceutical Osteoarthritis Pain Drugs Product
Table 107. Jingfeng Pharmaceutical Recent Developments/Updates
Table 108. Seikagaku Corporation Corporation Information
Table 109. Seikagaku Corporation Description and Business Overview
Table 110. Seikagaku Corporation Osteoarthritis Pain Drugs Sales (M Dose), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 111. Seikagaku Corporation Osteoarthritis Pain Drugs Product
Table 112. Seikagaku Corporation Recent Developments/Updates
Table 113. GSK Corporation Information
Table 114. GSK Description and Business Overview
Table 115. GSK Osteoarthritis Pain Drugs Sales (M Dose), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 116. GSK Osteoarthritis Pain Drugs Product
Table 117. GSK Recent Developments/Updates
Table 118. Sanofi Corporation Information
Table 119. Sanofi Description and Business Overview
Table 120. Sanofi Osteoarthritis Pain Drugs Sales (M Dose), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 121. Sanofi Osteoarthritis Pain Drugs Product
Table 122. Sanofi Recent Developments/Updates
Table 123. Crystal Genomics Corporation Information
Table 124. Crystal Genomics Description and Business Overview
Table 125. Crystal Genomics Osteoarthritis Pain Drugs Sales (M Dose), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 126. Crystal Genomics Osteoarthritis Pain Drugs Product
Table 127. Crystal Genomics Recent Developments/Updates
Table 128. Johnson & Johnson Corporation Information
Table 129. Johnson & Johnson Description and Business Overview
Table 130. Johnson & Johnson Osteoarthritis Pain Drugs Sales (M Dose), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 131. Johnson & Johnson Osteoarthritis Pain Drugs Product
Table 132. Johnson & Johnson Recent Developments/Updates
Table 133. GlaxoSmithKline Corporation Information
Table 134. GlaxoSmithKline Description and Business Overview
Table 135. GlaxoSmithKline Osteoarthritis Pain Drugs Sales (M Dose), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 136. GlaxoSmithKline Osteoarthritis Pain Drugs Product
Table 137. GlaxoSmithKline Recent Developments/Updates
Table 138. Mylan Corporation Information
Table 139. Mylan Description and Business Overview
Table 140. Mylan Osteoarthritis Pain Drugs Sales (M Dose), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 141. Mylan Osteoarthritis Pain Drugs Product
Table 142. Mylan Recent Developments/Updates
Table 143. Lilly Corporation Information
Table 144. Lilly Description and Business Overview
Table 145. Lilly Osteoarthritis Pain Drugs Sales (M Dose), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 146. Lilly Osteoarthritis Pain Drugs Product
Table 147. Lilly Recent Developments/Updates
Table 148. Abbott Laboratories Corporation Information
Table 149. Abbott Laboratories Description and Business Overview
Table 150. Abbott Laboratories Osteoarthritis Pain Drugs Sales (M Dose), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 151. Abbott Laboratories Osteoarthritis Pain Drugs Product
Table 152. Abbott Laboratories Recent Developments/Updates
Table 153. Almatica Pharma Corporation Information
Table 154. Almatica Pharma Description and Business Overview
Table 155. Almatica Pharma Osteoarthritis Pain Drugs Sales (M Dose), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 156. Almatica Pharma Osteoarthritis Pain Drugs Product
Table 157. Almatica Pharma Recent Developments/Updates
Table 158. TEVA Corporation Information
Table 159. TEVA Description and Business Overview
Table 160. TEVA Osteoarthritis Pain Drugs Sales (M Dose), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 161. TEVA Osteoarthritis Pain Drugs Product
Table 162. TEVA Recent Developments/Updates
Table 163. Iroko Pharmaceuticals Corporation Information
Table 164. Iroko Pharmaceuticals Description and Business Overview
Table 165. Iroko Pharmaceuticals Osteoarthritis Pain Drugs Sales (M Dose), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 166. Iroko Pharmaceuticals Osteoarthritis Pain Drugs Product
Table 167. Iroko Pharmaceuticals Recent Developments/Updates
Table 168. Production Base and Market Concentration Rate of Raw Material
Table 169. Key Suppliers of Raw Materials
Table 170. Osteoarthritis Pain Drugs Distributors List
Table 171. Osteoarthritis Pain Drugs Customers List
Table 172. Osteoarthritis Pain Drugs Market Trends
Table 173. Osteoarthritis Pain Drugs Growth Drivers
Table 174. Osteoarthritis Pain Drugs Market Restraints
Table 175. Global Osteoarthritis Pain Drugs Sales Forecast by Type (2022-2027) & (M Dose)
Table 176. Global Osteoarthritis Pain Drugs Sales Market Share Forecast by Type (2022-2027)
Table 177. Global Osteoarthritis Pain Drugs Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 178. Global Osteoarthritis Pain Drugs Revenue Market Share Forecast by Type (2022-2027)
Table 179. Global Osteoarthritis Pain Drugs Sales Forecast by Application (2022-2027) & (M Dose)
Table 180. Global Osteoarthritis Pain Drugs Sales Market Share Forecast by Application (2022-2027)
Table 181. Global Osteoarthritis Pain Drugs Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 182. Global Osteoarthritis Pain Drugs Revenue Market Share Forecast by Application (2022-2027)
Table 183. Global Osteoarthritis Pain Drugs Sales Forecast by Region (2022-2027) & (M Dose)
Table 184. Global Osteoarthritis Pain Drugs Sales Market Share Forecast by Region (2022-2027)
Table 185. Global Osteoarthritis Pain Drugs Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 186. Global Osteoarthritis Pain Drugs Revenue Market Share Forecast by Region (2022-2027)
Table 187. Research Programs/Design for This Report
Table 188. Key Data Information from Secondary Sources
Table 189. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Osteoarthritis Pain Drugs
Figure 2. Global Osteoarthritis Pain Drugs Market Share by Type in 2020 & 2027
Figure 3. Oral Product Picture
Figure 4. Injection Product Picture
Figure 5. External Product Picture
Figure 6. Global Osteoarthritis Pain Drugs Market Share by Application in 2020 & 2027
Figure 7. Medical Care
Figure 8. Personal Care
Figure 9. Global Osteoarthritis Pain Drugs Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Osteoarthritis Pain Drugs Market Size 2016-2027 (US$ Million)
Figure 11. Global Osteoarthritis Pain Drugs Sales 2016-2027 (M Dose)
Figure 12. Global Osteoarthritis Pain Drugs Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 13. Osteoarthritis Pain Drugs Sales Share by Manufacturers in 2020
Figure 14. Global Osteoarthritis Pain Drugs Revenue Share by Manufacturers in 2020
Figure 15. The Global 5 and 10 Largest Osteoarthritis Pain Drugs Players: Market Share by Revenue in 2020
Figure 16. Osteoarthritis Pain Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 17. Global Osteoarthritis Pain Drugs Sales Market Share by Region (2016-2021)
Figure 18. Global Osteoarthritis Pain Drugs Sales Market Share by Region in 2020
Figure 19. Global Osteoarthritis Pain Drugs Revenue Market Share by Region (2016-2021)
Figure 20. Global Osteoarthritis Pain Drugs Revenue Market Share by Region in 2020
Figure 21. U.S. Osteoarthritis Pain Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 22. Canada Osteoarthritis Pain Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. Germany Osteoarthritis Pain Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. France Osteoarthritis Pain Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. U.K. Osteoarthritis Pain Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Italy Osteoarthritis Pain Drugs Revenue Growth Rate (2016-2021)

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Sodium Hyaluronate Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 97

Hyaluronic acid (HA) is a naturally occurring polymer found throughout The body. HA is vital for maintaining The function of healthy tissue, and can be used for a variety of applications.In this report we include Hyaluronic Acid Sodium Injection for Beauty industry and Therapy. The global Sodium Hyaluronate market was valued at US$ 357 million in 2023 and is anticipated to reach US$ 1237.4 million by 2030, witnessing a CAGR of 19.2% during The forecast period 2024-2030. Globa......

Global Sodium Hyaluronate Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 116

According to our LPI (LP Information) latest study, the global Sodium Hyaluronate market size was valued at US$ 349.2 million in 2023. With growing demand in downstream market, the Sodium Hyaluronate is forecast to a readjusted size of US$ 1245.4 million by 2030 with a CAGR of 19.9% during review period. The research report highlights the growth potential of the global Sodium Hyaluronate market. Sodium Hyaluronate are expected to show stable growth in the future market. However, product ......

Global Osteoarthritis Pain Drugs Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 149

According to our LPI (LP Information) latest study, the global Osteoarthritis Pain Drugs market size was valued at US$ 9601.5 million in 2023. With growing demand in downstream market, the Osteoarthritis Pain Drugs is forecast to a readjusted size of US$ 14350 million by 2030 with a CAGR of 5.9% during review period. The research report highlights the growth potential of the global Osteoarthritis Pain Drugs market. Osteoarthritis Pain Drugs are expected to show stable growth in the futur......

Global Sodium Hyaluronate Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 112

According to our (Global Info Research) latest study, the global Sodium Hyaluronate market size was valued at USD 367.3 million in 2023 and is forecast to a readjusted size of USD 1196.4 million by 2030 with a CAGR of 18.4% during review period. Hyaluronic acid (HA) is a naturally occurring polymer found throughout the body. HA is vital for maintaining the function of healthy tissue, and can be used for a variety of applications.In this report we include Hyaluronic Acid Sodium Injection ......

Global Rheumatoid Arthritis Drug Professional Survey Report 2023, Forecast to 2028

Published: 22-Dec-2023        Price: US 3280 Onwards        Pages: 105

Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product launches, and market capital flows are compared across scenarios to demonstrate their impact over the forecast period. D......

Global Rheumatoid Arthritis Drug Market Research Report 2023, Forecast to 2028

Published: 22-Dec-2023        Price: US 2680 Onwards        Pages: 162

Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product launches, and market capital flows are compared across scenarios to demonstrate their impact over the forecast period. D......

Global Sulfasalazine Market Research Report 2023, Forecast to 2028

Published: 28-Nov-2023        Price: US 2680 Onwards        Pages: 165

Sulfasalazine (SSZ), sold under the trade name Azulfidine among others, is a medication used to treat rheumatoid arthritis, ulcerative colitis, and Crohn's disease. It is considered by some to be a first-line treatment in rheumatoid arthritis. It is taken by mouth. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segme......

Global Sulfasalazine Professional Survey Report 2023, Forecast to 2028

Published: 28-Nov-2023        Price: US 3280 Onwards        Pages: 131

Sulfasalazine (SSZ), sold under the trade name Azulfidine among others, is a medication used to treat rheumatoid arthritis, ulcerative colitis, and Crohn's disease. It is considered by some to be a first-line treatment in rheumatoid arthritis. It is taken by mouth. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segme......

Global Osteoarthritis Pain Drugs Market Research Report 2023, Forecast to 2028

Published: 20-Nov-2023        Price: US 2680 Onwards        Pages: 158

Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product launches, and market capital flows are compared across scenarios to demonstrate their impact over the forecast period. D......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs